Prostate cancer (PCa) is the most diagnosed cancer in men, accounting for 29% of all cancer diagnoses, and the second most common cause of cancer deaths in men, after lung cancer [1]. Diagnosis usually follows a routine screening of male adults through rectal examination, prostate-specific antigen (PSA) testing and MRI scan [2]. The gene discussed is KLK3; the disease is lung carcinoma.